{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:49:42Z","timestamp":1789951782414,"version":"4.0.1"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense award","doi-asserted-by":"publisher","award":["W81WXH-13-1-0141"],"award-info":[{"award-number":["W81WXH-13-1-0141"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH awards","doi-asserted-by":"publisher","award":["CA137844"],"award-info":[{"award-number":["CA137844"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH awards","doi-asserted-by":"publisher","award":["U54CA156735"],"award-info":[{"award-number":["U54CA156735"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH awards","doi-asserted-by":"publisher","award":["P20CA202924"],"award-info":[{"award-number":["P20CA202924"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH awards","doi-asserted-by":"publisher","award":["T32CA009111"],"award-info":[{"award-number":["T32CA009111"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Komen Graduate Training in Disparities Research award","award":["GTDR16377604"],"award-info":[{"award-number":["GTDR16377604"]}]},{"name":"Duke Consortium for IBC funds"},{"name":"Golden LEAF Foundation"},{"name":"BIOIMPACT Initiative of the State of North Carolina"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.canlet.2017.09.033","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T08:46:32Z","timestamp":1506674792000},"page":"136-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in\u00a0vivo tumor growth of inflammatory breast cancer cells"],"prefix":"10.1016","volume":"411","author":[{"given":"Helen O.","family":"Oladapo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tarpley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezia A.","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalonda M.","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon","family":"Strepay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben K.","family":"Ehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lhoucine","family":"Chdid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Roques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Darr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie M.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri R.","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6930-4630","authenticated-orcid":false,"given":"Kevin P.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2017.09.033_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jclinpath-2012-201361","article-title":"Therapeutic targets in triple negative breast cancer","volume":"66","author":"O'Toole","year":"2013","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.canlet.2017.09.033_bib2","first-page":"995","article-title":"Overexpression of Hedgehog signaling molecules and its involvement in triple-negative breast cancer","volume":"2","author":"Tao","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.09.033_bib3","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/cam4.833","article-title":"The hedgehog pathway in triple-negative breast cancer","volume":"5","author":"Habib","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2017.09.033_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrclinonc.2013.29","article-title":"Emerging targeted agents in metastatic breast cancer","volume":"10","author":"Zardavas","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.09.033_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.09.033_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ejca.2005.08.039","article-title":"GLI transcription factors: mediators of oncogenic Hedgehog signalling","volume":"42","author":"Kasper","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/332371a0","article-title":"The GLI gene is a member of the Kruppel family of zinc finger proteins","volume":"332","author":"Kinzler","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2017.09.033_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nrc1229","article-title":"Hedgehog signalling in cancer formation and maintenance","volume":"3","author":"Pasca di Magliano","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/138920210791233108","article-title":"The Human Glioma-Associated Oncogene Homolog 1 (GLI1) family of transcription factors in gene regulation and diseases","volume":"11","author":"Zhu","year":"2010","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.canlet.2017.09.033_bib10","first-page":"457","article-title":"The Hedgehog pathway as a drug target in cancer therapy","volume":"8","author":"Lauth","year":"2007","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.canlet.2017.09.033_bib11","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bcp.2010.04.016","article-title":"Small molecule modulation of HH-GLI signaling: current leads, trials and tribulations","volume":"80","author":"Mas","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2017.09.033_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1039\/B910196A","article-title":"Small-molecule modulators of the Sonic Hedgehog signaling pathway","volume":"6","author":"Stanton","year":"2010","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.canlet.2017.09.033_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tips.2009.03.007","article-title":"Mechanisms of Hedgehog pathway activation in cancer and implications for therapy","volume":"30","author":"Scales","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2017.09.033_bib14","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s40265-015-0458-y","article-title":"Sonidegib: first global approval","volume":"75","author":"Burness","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.canlet.2017.09.033_bib15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1179386","article-title":"Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma","volume":"326","author":"Yauch","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.canlet.2017.09.033_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/0008-5472.CAN-10-2876","article-title":"Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance","volume":"71","author":"Dijkgraaf","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.033_bib17","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-11-0923","article-title":"Hedgehog fights back: mechanisms of acquired resistance against smoothened antagonists","volume":"71","author":"Metcalfe","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.033_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.devcel.2008.11.010","article-title":"Hedgehog signaling in development and cancer","volume":"15","author":"Jiang","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.canlet.2017.09.033_bib19","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-08-3938","article-title":"Development of mammary tumors by conditional expression of GLI1","volume":"69","author":"Fiaschi","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.033_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2174\/156652409789105570","article-title":"Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation","volume":"9","author":"Katoh","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.canlet.2017.09.033_bib21","doi-asserted-by":"crossref","first-page":"22888","DOI":"10.1074\/jbc.M109.021949","article-title":"The Hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating Osteopontin","volume":"284","author":"Das","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.09.033_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/onc.2010.459","article-title":"GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin","volume":"30","author":"Inaguma","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.09.033_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000098111","article-title":"Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma","volume":"70","author":"Mori","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2017.09.033_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1349-7006.2008.00822.x","article-title":"Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase 9 activation","volume":"99","author":"Nagai","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2017.09.033_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-9-298","article-title":"Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival","volume":"9","author":"ten Haaf","year":"2009","journal-title":"Bmc Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-009-0617-5","article-title":"Gli1 promotes cell survival and is predictive of a poor outcome in ER -negative breast cancer","volume":"123","author":"Xu","year":"2010","journal-title":"Breast cancer Res. Treat."},{"key":"10.1016\/j.canlet.2017.09.033_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11060-009-0082-3","article-title":"Gli1 inhibition induces cell-cycle arrest and enhanced apoptosis in brain glioma cell lines","volume":"98","author":"Wang","year":"2010","journal-title":"J.\u00a0neuro-oncology"},{"key":"10.1016\/j.canlet.2017.09.033_bib28","first-page":"475","article-title":"Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype","volume":"27","author":"Li","year":"2012","journal-title":"Histology Histopathol."},{"key":"10.1016\/j.canlet.2017.09.033_bib29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2011.133","article-title":"Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration","volume":"104","author":"Thomas","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib30","article-title":"Molecular determinants of the inflammatory breast cancer phenotype","volume":"22","author":"Houchens","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2017.09.033_bib31","doi-asserted-by":"crossref","first-page":"R112","DOI":"10.1186\/bcr3579","article-title":"Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers","volume":"15","author":"Masuda","year":"2013","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.033_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.seminoncol.2007.11.015","article-title":"Defining the molecular biology of inflammatory breast cancer","volume":"35","author":"Charafe-Jauffret","year":"2008","journal-title":"Seminars Oncol."},{"key":"10.1016\/j.canlet.2017.09.033_bib33","first-page":"351","article-title":"Inflammatory breast cancer: the disease, the biology, the treatment","volume":"60","author":"Robertson","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2017.09.033_bib34","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/cncr.25180","article-title":"Is there a role for mammary stem cells in inflammatory breast carcinoma?","volume":"116","author":"Van Laere","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib35","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1158\/1535-7163.MCT-10-0160","article-title":"X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1\/2 tyrosine kinase inhibitor","volume":"9","author":"Aird","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2017.09.033_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00432-006-0140-6","article-title":"Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in\u00a0vitro","volume":"133","author":"Dong","year":"2007","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.09.033_bib37","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/sj.bjc.6695007","article-title":"Molecular cytogenetic analysis of 11 new breast cancer cell lines","volume":"81","author":"Forozan","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2867-5-11","article-title":"In\u00a0vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line","volume":"5","author":"Hoffmeyer","year":"2005","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2017.09.033_bib39","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1002\/cncr.25181","article-title":"Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers","volume":"116","author":"Wu","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.cellsig.2009.01.033","article-title":"Hedgehog signalling: emerging evidence for non-canonical pathways","volume":"21","author":"Jenkins","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2017.09.033_bib41","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.4161\/cc.6.20.4808","article-title":"Non-canonical activation of GLI transcription factors:\u00a0implications for targeted anti-cancer therapy","volume":"6","author":"Lauth","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2017.09.033_bib42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbcan.2015.06.003","article-title":"Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy","volume":"1856","author":"Di Magno","year":"2015","journal-title":"Biochimica Biophysica Acta (BBA)-Reviews Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib43","doi-asserted-by":"crossref","first-page":"13899","DOI":"10.18632\/oncotarget.4224","article-title":"Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened","volume":"6","author":"Gonnissen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.033_bib44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.15252\/embj.201489213","article-title":"Gli1\/DNA interaction is a druggable target for Hedgehog-dependent tumors","volume":"34","author":"Infante","year":"2015","journal-title":"Embo J."},{"key":"10.1016\/j.canlet.2017.09.033_bib45","doi-asserted-by":"crossref","first-page":"14132","DOI":"10.1073\/pnas.0907134106","article-title":"Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade","volume":"106","author":"Hyman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2017.09.033_bib46","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0609699104","article-title":"Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists","volume":"104","author":"Lauth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2017.09.033_bib47","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cbic.200700403","article-title":"A\u00a0small-molecule antagonist of the hedgehog signaling pathway","volume":"8","author":"Lee","year":"2007","journal-title":"Chembiochem"},{"key":"10.1016\/j.canlet.2017.09.033_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/jm900106f","article-title":"Structure activity relationships and cancer-cell selective toxicity of novel inhibitors of glioma-associated oncogene homologue 1 (Gli1) mediated transcription","volume":"52","author":"Mahindroo","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.canlet.2017.09.033_bib49","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1021\/jm801420y","article-title":"Hedgehog-Gli signaling pathway inhibitors as anticancer agents","volume":"52","author":"Mahindroo","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.canlet.2017.09.033_bib50","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-11-0950","article-title":"Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma","volume":"18","author":"Xu","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.033_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccr.2012.11.017","article-title":"Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists","volume":"23","author":"Kim","year":"2013","journal-title":"Cancer cell"},{"key":"10.1016\/j.canlet.2017.09.033_bib52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.abb.2014.12.014","article-title":"Design and characterization of a photo-activatable hedgehog probe that mimics the natural lipidated form","volume":"567","author":"House","year":"2015","journal-title":"Archives Biochem. Biophysics"},{"issue":"Pt 23","key":"10.1016\/j.canlet.2017.09.033_bib53","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1242\/jcs.112.23.4405","article-title":"Functional antagonists of sonic hedgehog reveal the importance of the N terminus for activity","volume":"112","author":"Williams","year":"1999","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.canlet.2017.09.033_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/carcin\/bgx003","article-title":"Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells","volume":"38","author":"Sauer","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2017.09.033_bib55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/1087057108318428","article-title":"Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans","volume":"13","author":"Abraham","year":"2008","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.canlet.2017.09.033_bib56","article-title":"Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies","volume":"5","author":"Arora","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.033_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10549-011-1568-1","article-title":"ErbB1\/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells","volume":"132","author":"Aird","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2017.09.033_bib58","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J.\u00a0Clin. investigation"},{"key":"10.1016\/j.canlet.2017.09.033_bib59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s13058-014-0444-4","article-title":"Significance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NF inverted question markB) pathway","volume":"16","author":"Colavito","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.033_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8020022","article-title":"Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors","volume":"8","author":"Rimkus","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2017.09.033_bib61","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1523-1747.2000.00951.x","article-title":"Conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration","volume":"114","author":"Wang","year":"2000","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.canlet.2017.09.033_bib62","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1101\/gad.1025302","article-title":"Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened","volume":"16","author":"Chen","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2017.09.033_bib63","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1074\/jbc.M310589200","article-title":"Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1","volume":"279","author":"Bigelow","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.09.033_bib64","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.1128\/MCB.20.23.9055-9067.2000","article-title":"Sonic hedgehog promotes G1 cyclin expression and sustained cell cycle progression in mammalian neuronal precursors","volume":"20","author":"Kenney","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2017.09.033_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.taap.2005.06.006","article-title":"Characterization of the activities of actin-affecting drugs on tumor cell migration","volume":"211","author":"Hayot","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.canlet.2017.09.033_bib66","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.biotechadv.2014.07.009","article-title":"Three-dimensional in\u00a0vitro tumor models for cancer research and drug evaluation","volume":"32","author":"Xu","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.canlet.2017.09.033_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/adt.2015.670","article-title":"Drug discovery approaches utilizing three-dimensional cell culture","volume":"14","author":"Ryan","year":"2016","journal-title":"Assay drug Dev. Technol."},{"key":"10.1016\/j.canlet.2017.09.033_bib68","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/or.2015.3767","article-title":"Comparison of 2D-and 3D-culture models as drug-testing platforms in breast cancer","volume":"33","author":"Imamura","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.09.033_bib69","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/ijc.27928","article-title":"Modeling and characterization of inflammatory breast cancer emboli grown in\u00a0vitro","volume":"132","author":"Lehman","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib70","doi-asserted-by":"crossref","first-page":"84286","DOI":"10.18632\/oncotarget.12483","article-title":"The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in\u00a0vitro and in\u00a0vivo","volume":"7","author":"Gonnissen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.033_bib71","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/1078-0432.CCR-13-2195","article-title":"Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer","volume":"20","author":"Huang","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.033_bib72","doi-asserted-by":"crossref","first-page":"12151","DOI":"10.18632\/oncotarget.2569","article-title":"GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh\/AKT-mTOR axis","volume":"5","author":"Srivastava","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.033_bib73","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/ijc.27820","article-title":"Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in\u00a0vitro and in\u00a0vivo","volume":"132","author":"Wickstrom","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2013.05.017","article-title":"Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization","volume":"337","author":"Williams","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.09.033_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123312","article-title":"In\u00a0vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening","volume":"10","author":"Benton","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.canlet.2017.09.033_bib76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.canlet.2017.09.033_bib77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molonc.2007.02.004","article-title":"The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression","volume":"1","author":"Kenny","year":"2007","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2017.09.033_bib78","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.18632\/oncotarget.2046","article-title":"Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding","volume":"5","author":"Agyeman","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.033_bib79","doi-asserted-by":"crossref","first-page":"80190","DOI":"10.18632\/oncotarget.13376","article-title":"Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.033_bib80","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-13-137","article-title":"Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation","volume":"13","author":"Sun","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib81","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10549-008-0093-3","article-title":"Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo)","volume":"115","author":"Zhang","year":"2009","journal-title":"Breast cancer Res. Treat."},{"key":"10.1016\/j.canlet.2017.09.033_bib82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-009-0323-3","article-title":"Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth","volume":"119","author":"Zhao","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2017.09.033_bib83","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s12282-017-0757-0","article-title":"Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells","volume":"24","author":"Koike","year":"2017","journal-title":"Breast Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib84","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.18632\/oncotarget.7062","article-title":"In\u00a0vitro and in\u00a0vivo inhibition of breast cancer cell growth by targeting the Hedgehog\/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors","volume":"7","author":"Benvenuto","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.033_bib85","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/bjc.2017.116","article-title":"Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers","volume":"116","author":"Di Mauro","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.09.033_bib86","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/anie.200805666","article-title":"The imidazopyridine derivative JK184 reveals dual roles for microtubules in Hedgehog signaling","volume":"48","author":"Cupido","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.canlet.2017.09.033_bib87","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1158\/0008-5472.CAN-10-4173","article-title":"Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells","volume":"71","author":"Mazumdar","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.033_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013054","article-title":"cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells","volume":"5","author":"Shi","year":"2010","journal-title":"PloS one"},{"key":"10.1016\/j.canlet.2017.09.033_bib89","doi-asserted-by":"crossref","DOI":"10.2174\/2213988501408010027","article-title":"Live multicellular tumor spheroid models for high-content imaging and screening in cancer drug discovery","volume":"8","author":"Reid","year":"2014","journal-title":"Curr. Chem. genomics Transl. Med."},{"key":"10.1016\/j.canlet.2017.09.033_bib90","doi-asserted-by":"crossref","first-page":"45745","DOI":"10.18632\/oncotarget.9935","article-title":"The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance","volume":"7","author":"Breslin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.033_bib91","first-page":"203","article-title":"Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT\u2013mTOR\u2013S6K signaling and drug responses","volume":"130","author":"Riedl","year":"2017","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.canlet.2017.09.033_bib92","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/sj.onc.1205389","article-title":"Cooperative role of E-cadherin and sialyl-Lewis X\/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma","volume":"21","author":"Alpaugh","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.09.033_bib93","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/bcr89","article-title":"Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants","volume":"2","author":"Kleer","year":"2000","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.033_bib94","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2012.11.018","article-title":"GANT-61 inhibits pancreatic cancer stem cell growth in\u00a0vitro and in NOD\/SCID\/IL2R gamma null mice xenograft","volume":"330","author":"Fu","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.09.033_bib95","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.canlet.2016.10.034","article-title":"Anti-proliferation of breast cancer cells with itraconazole: hedgehog pathway inhibition induces apoptosis and autophagic cell death","volume":"385","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.09.033_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00130","article-title":"Hedgehog inhibitors in rhabdomyosarcoma: a comparison of four compounds and responsiveness of four cell lines","volume":"5","author":"Ridzewski","year":"2015","journal-title":"Front. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517305864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517305864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:38:45Z","timestamp":1759592325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383517305864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":96,"alternative-id":["S0304383517305864"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2017.09.033","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in\u00a0vivo tumor growth of inflammatory breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2017.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}